151 related articles for article (PubMed ID: 23086509)
1. Limitation in the assessment of baseline lymphomatous bone marrow involvement by FDG-PET/CT scan.
Hong J; Lee JH
Ann Hematol; 2013 Apr; 92(4):565-6. PubMed ID: 23086509
[No Abstract] [Full Text] [Related]
2. Using a cut-off SUV level to define bone marrow lesions on FDG PET is not appropriate.
Cheng G
Ann Hematol; 2013 Jan; 92(2):283-4. PubMed ID: 22885991
[No Abstract] [Full Text] [Related]
3. Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma.
Hong J; Lee Y; Park Y; Kim SG; Hwang KH; Park SH; Jeong J; Kim KH; Ahn JY; Park S; Park J; Lee JH
Ann Hematol; 2012 May; 91(5):687-695. PubMed ID: 22008868
[TBL] [Abstract][Full Text] [Related]
4. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of imaging-based bone marrow assessment in lymphoma: 18F-FDG PET, MR imaging, or 18F-FDG PET/MR imaging?
Adams HJ; Kwee TC; Nievelstein RA
J Nucl Med; 2013 Nov; 54(11):2017-8. PubMed ID: 24009274
[No Abstract] [Full Text] [Related]
6. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
7. Reply: Prognostic implications of imaging-based bone marrow assessment in lymphoma: 18F-FDG PET, MR imaging, or 18F-FDG PET/MR imaging?
Berthet L; Humbert O; Cochet A
J Nucl Med; 2013 Nov; 54(11):2018. PubMed ID: 24029654
[No Abstract] [Full Text] [Related]
8. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Acta Radiol; 2015 Oct; 56(10):1230-5. PubMed ID: 25387723
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow metastases from alveolar rhabdomyosarcoma with impressive FDG PET/CT finding but less-revealing bone scintigraphy.
Yang J; Zhen L; Zhuang H
Clin Nucl Med; 2013 Dec; 38(12):988-91. PubMed ID: 24152640
[TBL] [Abstract][Full Text] [Related]
11. Bilateral cutaneous diffuse large B-cell lymphoma on FDG PET/CT.
Kalender E; Yilmaz M; Erkilic S; Yilmaz M; Celen Z
Clin Nucl Med; 2011 Oct; 36(10):e153-5. PubMed ID: 21892030
[No Abstract] [Full Text] [Related]
12. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
Lin CY; Chen YW; Chang CC; Yang WC; Huang CJ; Hou MF
Kaohsiung J Med Sci; 2013 Apr; 29(4):229-33. PubMed ID: 23541269
[TBL] [Abstract][Full Text] [Related]
13. Early bone marrow metastasis detection: the additional value of FDG-PET/CT vs. CT imaging.
Evangelista L; Panunzio A; Polverosi R; Ferretti A; Chondrogiannis S; Pomerri F; Rubello D; Muzzio PC
Biomed Pharmacother; 2012 Sep; 66(6):448-53. PubMed ID: 22902054
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow evaluation in initial staging of lymphoma: 18F-FDG PET/CT versus bone marrow biopsy.
Cortés-Romera M; Sabaté-Llobera A; Mercadal-Vilchez S; Climent-Esteller F; Serrano-Maestro A; Gámez-Cenzano C; González-Barca E
Clin Nucl Med; 2014 Jan; 39(1):e46-52. PubMed ID: 23640215
[TBL] [Abstract][Full Text] [Related]
15. Peripheral bone involvement of intravascular large B-cell lymphoma on 99mTc-MDP bone scan and 18F-FDG PET/CT.
Oh SY; Cheon GJ; Jeong E; Lee S; Park TG; Pahk K; Choe JG
Clin Nucl Med; 2012 Aug; 37(8):810-1. PubMed ID: 22785520
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/CT diagnosis of vagus nerve neurolymphomatosis.
Tsang HH; Lee EY; Anthony MP; Khong PL
Clin Nucl Med; 2012 Sep; 37(9):897-8. PubMed ID: 22889783
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET detection of primary bone marrow large B-cell lymphoma in a patient with hairy cell leukemia.
Paolini R; Bianchini E; D'Andrea E; Al-Nahhas A; Banti E; Muzzio PC; Rubello D
Nucl Med Rev Cent East Eur; 2007; 10(1):23-5. PubMed ID: 17694498
[TBL] [Abstract][Full Text] [Related]
18. An unusual case of diffuse large B-cell lymphoma involving the vulva evaluated by 18F-FDG PET/CT.
Treglia G; Paone G; Perriard U; Ceriani L; Giovanella L
Clin Nucl Med; 2014 Oct; 39(10):e439-41. PubMed ID: 24152653
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Importance of Bone Marrow Uptake on Baseline
Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
[TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin lymphoma dominated by multiple organ extranodal disease revealed on FDG PET/CT.
Bai X; Codreanu I; Kaplan SL; Servaes S; Zhuang H
Clin Nucl Med; 2015 Apr; 40(4):360-3. PubMed ID: 25608171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
